Skip to main content
SpringerLink
Log in

Current status of a recombinant antihemophilic factor VIII clinical trial organized by Baxter

  • Symposium
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  1. White GC, McMillan GW, Kingdon GS, Shoemaker GB (1989) Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia. N Engl J Med 320 (3): 166–170

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Hospital, Frankfurt/Main, FRG

    I. Scharrer

Authors
  1. I. Scharrer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scharrer, I. Current status of a recombinant antihemophilic factor VIII clinical trial organized by Baxter. Ann Hematol 63, 172–176 (1991). https://doi.org/10.1007/BF01703250

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01703250

Keywords

Search

Navigation